Search Results for: aspen neuroscience

Weekly reads: upbeat early Aspen stem cells for Parkinson’s trial data, Capricor, hematopoietic editing

Autologous iPSC-derived neurons, stem cells for Parkinson's

I recently wrote about the upbeat early reports from two allogeneic trials of stem cells for Parkinson’s. Now there’s additional encouraging early news on this front but using patients’ own cells. This is one of the most promising areas of regenerative medicine. Stem cells for Parkinson’s: Aspen Neuroscience upbeat early data California biotech Aspen Neuroscience […]

Weekly reads: upbeat early Aspen stem cells for Parkinson’s trial data, Capricor, hematopoietic editing Read More »

Recommend reads: FDA SVF warning, big Aspen grant, CSI finale invokes stem cells

SVF

One of the most contentious areas in the regenerative medicine arena is whether a fat tissue product called stromal vascular fraction or SVF is a drug. The FDA says SVF, even in autologous form, is a drug. It is seeking an injunction against a California-based network of SVF clinics but lost the initial case. That

Recommend reads: FDA SVF warning, big Aspen grant, CSI finale invokes stem cells Read More »

Recommended reads: police act on phony autism cure, Aspen starts Parkinson’s trial, reprogramming to iBlastoids

stem cells for autism

People often ask me about stem cells for autism or even their hope of an autism cure. I’ve explained that there is no new treatment for autism based on stem cells. There aren’t even mildly encouraging data. Note that it can be hurtful to the community to talk about an autism cure and disregarding neurodiversity.

Recommended reads: police act on phony autism cure, Aspen starts Parkinson’s trial, reprogramming to iBlastoids Read More »

Poll on stem cell & regenerative medicine good news of 2024

stem cell good news, good news

What are the most significant stem cell and regenerative medicine good news stories of 2024? Since it has been an eventful year, there are many possibilities. Please see our poll at the bottom of this post and weigh in on what you think is the most important encouraging news. If you don’t see your choice

Poll on stem cell & regenerative medicine good news of 2024 Read More »

Recommended reads: Stem cells in Japan, iPS cells for COVID & hearts, He Jiankui

fruit fly intestine, stem cells in Japan

How are things going with regenerative medicine and stem cells in Japan? It’s still an exciting time there, but I’ve noted a sense that it is a time of transition too in some ways. For example, government funding is perhaps less certain than in the past. Let’s start with a few articles on how the

Recommended reads: Stem cells in Japan, iPS cells for COVID & hearts, He Jiankui Read More »

Recent stem cell & regenerative medicine good news

stem cell good news, good news

Looking for some stem cell good news? You’ll like today’s post. One mission of this blog The Niche is to promote rigorous science-based regenerative medicine, which can lead to investigating and writing about not-so-upbeat stuff. Risky clinics. People getting hurt. Patient lawsuits. Serious FDA, FTC, or state AG regulatory developments. Such actions can be good

Recent stem cell & regenerative medicine good news Read More »

Weekly reads: stem cells for MS, good news x2, extending dog years, Neuralink updates

stem cells for MS

For about as long as I’ve been writing The Niche, people have been asking about stem cells for MS. There’s a huge need for new therapies. While a chemo-based approach with autologous hematopoietic stem cell transplantation (HSCT) looks to work for certain cases of multiple sclerosis (although not yet approved in the US), other cell

Weekly reads: stem cells for MS, good news x2, extending dog years, Neuralink updates Read More »

Weekly reads: big Retraction Watch news, stem cells & metastasis, an FDA approval, Iowa AG sues clinic

Retraction watch

Retraction Watch has been a great resource for those of us who have been following research misconduct. They widely cover and conduct research on retractions, corrections, and other developments in this space. Unfortunately, there’s been plenty to write about even just within the stem cell and cell therapy arena, which is my primary interest. Think

Weekly reads: big Retraction Watch news, stem cells & metastasis, an FDA approval, Iowa AG sues clinic Read More »

Weekly reads: embryonic stem cells, Parkinson’s, Alzheimer’s

Knoepfler lab stem cells

Early during my postdoc I was primarily interested in the role of Myc genes both in cancer and in stem cells, work that later included embryonic stem cells. These cells are often called ES cells. At first I first started studying N-Myc in neural stem cells using a conditional knockout approach. However, soon after I was

Weekly reads: embryonic stem cells, Parkinson’s, Alzheimer’s Read More »